Our attitudes and behaviours are shaped by what others in society do. So there’s a real danger that vaccine hesitancy, when reported widely in the media, could catch on to more people.
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it’s better for individuals to mix what’s available.
Experts are continually monitoring how well COVID vaccines are working, their side effects, and the amount of disease in the community. These factors can change, and advice will adapt accordingly.
Hundreds of thousands of Canadians got a shot of AstraZeneca’s COVID-19 vaccine for their first dose. They now have a choice for their second dose: AstraZeneca again, or Pfizer or Moderna mRNA vaccine?
Kylie Quinn, RMIT University y Jennifer Juno, The Peter Doherty Institute for Infection and Immunity
The infection of a Victorian aged-worker who had received their first COVID vaccine dose isn’t completely surprising. We need two doses for optimal protection.
Answers to key questions about rare blood clots linked to AstraZeneca’s COVID-19 vaccine, including risks, symptoms and whether people who have had one AstraZeneca shot should have a second.
We want to get everybody vaccinated. Opening up to younger age groups could be one way to speed things up — but it will come with logistical challenges too.
Fiona Russell, The University of Melbourne; John Hart, Murdoch Children's Research Institute y Katherine Gibney, The Peter Doherty Institute for Infection and Immunity
The COVID-19 variant responsible for Victoria’s latest outbreak is one of three Indian variant sub-types, which spreads more easily than the original strain. Here’s what we know so far.